4//SEC Filing
Robinson Gregory Scott 4
Accession 0001209191-19-035576
CIK 0001711675other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:39 PM ET
Size
10.2 KB
Accession
0001209191-19-035576
Insider Transaction Report
Form 4
Robinson Gregory Scott
Chief Scientific Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2019-06-07$11.26/sh−75,000$844,500→ 0 totalExercise: $14.24Exp: 2028-01-30→ Ordinary Shares (75,000 underlying) - Disposition to Issuer
Ordinary Shares
2019-06-07$25.50/sh−103,182$2,631,141→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2019-06-07$10.76/sh−91,400$983,464→ 0 totalExercise: $14.74Exp: 2029-01-21→ Ordinary Shares (91,400 underlying)
Footnotes (3)
- [F1]The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the "Issuer") may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F2]In connection with the acquisition by Tungsten Bidco Limited of the entire issued and to be issued share capital of the Issuer on June 7, 2019 by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, all stock options were cancelled in exchange for a payment equal to $25.50 with respect to each ordinary share subject to the option award, less the applicable exercise price.
- [F3]Represents the payment per share received in exchange for the cancellation of each option of $25.50, less the applicable exercise price.
Documents
Issuer
Nightstar Therapeutics plc
CIK 0001711675
Entity typeother
Related Parties
1- filerCIK 0001761163
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:39 PM ET
- Size
- 10.2 KB